{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T02:19:25Z","timestamp":1788229165358,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":73,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16360-0","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T12:45:18Z","timestamp":1781959518000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic value of combined FIB-4 and AFP in predicting survival after hepatectomy for hepatocellular carcinoma: a multicenter cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Yuting","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haojie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangfeng","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxiang","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zemin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,20]]},"reference":[{"issue":"3","key":"16360_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA-Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA-Cancer J Clin"},{"issue":"5","key":"16360_CR2","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1159\/000530495","volume":"12","author":"J Zhou","year":"2023","unstructured":"Zhou J, Sun H, Wang Z, Cong W, Zeng M, Zhou W, Bie P, Liu L, Wen T, Kuang M, et al. Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition). Liver Cancer. 2023;12(5):405\u201344.","journal-title":"Liver Cancer"},{"issue":"1","key":"16360_CR3","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12943-024-02101-z","volume":"23","author":"Y Chan","year":"2024","unstructured":"Chan Y, Zhang C, Wu J, Lu P, Xu L, Yuan H, Feng Y, Chen Z, Wang N. Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma. Mol Cancer. 2024;23(1):189.","journal-title":"Mol Cancer"},{"issue":"1","key":"16360_CR4","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1097\/JS9.0000000000001879","volume":"111","author":"K Jiang","year":"2025","unstructured":"Jiang K, Li J, Liu Z, Chen M, Cai W, Liu L, Yin D. Impact of major hepatectomy on recurrence after resection of hepatocellular carcinoma at CNLC Ib stage: a propensity score matching study. Int J Surg. 2025;111(1):857\u201364.","journal-title":"Int J Surg"},{"issue":"2","key":"16360_CR5","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1159\/000533857","volume":"13","author":"K Yasukawa","year":"2024","unstructured":"Yasukawa K, Shimizu A, Kubota K, Notake T, Hosoda K, Hayashi H, Soejima Y. Impact of Liver Fibrosis Severity on Oncological Prognosis in Hepatocellular Carcinoma. Liver Cancer. 2024;13(2):150\u201360.","journal-title":"Liver Cancer"},{"issue":"9","key":"16360_CR6","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1002\/bjs.11231","volume":"106","author":"T Yang","year":"2019","unstructured":"Yang T, Liu K, Liu C, Zhong Q, Zhang J, Yu J, Liang L, Li C, Wang M, Li Z, et al. Impact of postoperative infective complications on long-term survival after liver resection for hepatocellular carcinoma. Brit J Surg. 2019;106(9):1228\u201336.","journal-title":"Brit J Surg"},{"key":"16360_CR7","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2147\/JHC.S297296","volume":"8","author":"D Galun","year":"2021","unstructured":"Galun D, Bogdanovic A, Zivanovic M, Zuvela M. Short- and Long-Term Outcomes After Hepatectomy in Elderly Patients with Hepatocellular Carcinoma: An Analysis of 229 Cases from a Developing Country. J Hepatocell Carcino. 2021;8:155\u201365.","journal-title":"J Hepatocell Carcino"},{"issue":"6","key":"16360_CR8","doi-asserted-by":"publisher","first-page":"100153","DOI":"10.1016\/j.jhepr.2020.100153","volume":"2","author":"C Hobeika","year":"2020","unstructured":"Hobeika C, Nault JC, Barbier L, Schwarz L, Lim C, Laurent A, Gay S, Salam\u00e9 E, Scatton O, Soubrane O, et al. Influence of surgical approach and quality of resection on the probability of cure for early-stage HCC occurring in cirrhosis. Jhep Rep. 2020;2(6):100153.","journal-title":"Jhep Rep"},{"issue":"6","key":"16360_CR9","first-page":"1784","volume":"20","author":"Y Wang","year":"2024","unstructured":"Wang Y, Yang X, Wang S. Progress and prospects of elastography techniques in the evaluation of fibrosis in chronic liver disease. Arch Med Sci. 2024;20(6):1784\u201392.","journal-title":"Arch Med Sci"},{"key":"16360_CR10","doi-asserted-by":"publisher","first-page":"615978","DOI":"10.3389\/fmed.2021.615978","volume":"8","author":"LJM Heyens","year":"2021","unstructured":"Heyens LJM, Busschots D, Koek GH, Robaeys G, Francque S. Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment. Front Med-Lausanne. 2021;8:615978.","journal-title":"Front Med-Lausanne"},{"issue":"1","key":"16360_CR11","doi-asserted-by":"publisher","first-page":"e187142","DOI":"10.1001\/jamanetworkopen.2018.7142","volume":"2","author":"FB Maegawa","year":"2019","unstructured":"Maegawa FB, Shehorn L, Aziz H, Kettelle J, Jie T, Riall TS. Association Between Noninvasive Fibrosis Markers and Postoperative Mortality After Hepatectomy for Hepatocellular Carcinoma. Jama Netw Open. 2019;2(1):e187142.","journal-title":"Jama Netw Open"},{"key":"16360_CR12","doi-asserted-by":"crossref","unstructured":"Kamada Y, Munekage K, Nakahara T, Fujii H, Sawai Y, Doi Y, Hyogo H, Sumida Y, Imai Y, Miyoshi E, et al. The FIB-4 index predicts the development of liver-related events, extrahepatic cancers, and coronary vascular disease in patients with NAFLD. Nutrients. 2022;15(1):66.","DOI":"10.3390\/nu15010066"},{"issue":"4","key":"16360_CR13","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4174\/astr.2023.104.4.195","volume":"104","author":"SO Yun","year":"2023","unstructured":"Yun SO, Kim JM, Rhu J, Choi G, Joh J. Fibrosis-4 index, a predictor for prognosis of hepatocellular carcinoma patients after curative hepatectomy even in hepatitis B virus dominant populations. Ann Surg Treat Res. 2023;104(4):195.","journal-title":"Ann Surg Treat Res"},{"issue":"1","key":"16360_CR14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/HEP.0000000000000707","volume":"80","author":"F \u00c5berg","year":"2024","unstructured":"\u00c5berg F, Asteljoki J, M\u00e4nnist\u00f6 V, Luukkonen PK. Combined use of the CLivD score and FIB-4 for prediction of liver-related outcomes in the population. Hepatology. 2024;80(1):163\u201372.","journal-title":"Hepatology"},{"issue":"5","key":"16360_CR15","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.ejso.2016.02.009","volume":"42","author":"J Dong","year":"2016","unstructured":"Dong J, Xu X, Ke M, Xiang J, Liu W, Liu X, Wang B, Zhang X, Lv Y. The FIB-4 score predicts postoperative short-term outcomes of hepatocellular carcinoma fulfilling the milan criteria. Ejso-Eur J Surg Onc. 2016;42(5):722\u20137.","journal-title":"Ejso-Eur J Surg Onc"},{"issue":"4","key":"16360_CR16","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.surg.2014.10.022","volume":"157","author":"H Toyoda","year":"2015","unstructured":"Toyoda H, Kumada T, Tada T, Kaneoka Y, Maeda A. A laboratory marker, FIB-4 index, as a predictor for long-term outcomes of hepatocellular carcinoma patients after curative hepatic resection. Surgery. 2015;157(4):699\u2013707.","journal-title":"Surgery"},{"issue":"4","key":"16360_CR17","doi-asserted-by":"publisher","first-page":"351","DOI":"10.5582\/bst.2019.01212","volume":"13","author":"J Zhang","year":"2019","unstructured":"Zhang J, Luo Y, Li C, Liu J, Xiang H, Wen T. The combination of the preoperative albumin-bilirubin grade and the fibrosis-4 index predicts the prognosis of patients with hepatocellular carcinoma after liver resection. Biosci Trends. 2019;13(4):351\u20137.","journal-title":"Biosci Trends"},{"issue":"6","key":"16360_CR18","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, Sulkowski S, Torriani M, Dieterich FJ, Thomas DT. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology. 2006;43(6):1317\u201325.","journal-title":"Hepatology"},{"key":"16360_CR19","first-page":"4305408","volume":"2018","author":"H Wang","year":"2018","unstructured":"Wang H, Liu A, Bo W, Feng X, Hu Y, Tian L, Zhang H, Tang X, Zhang L. Fibrosis-4 Model Influences Results of Patients with Hepatocellular Carcinoma Undergoing Hepatectomy. Biomed Res Int. 2018;2018:4305408.","journal-title":"Biomed Res Int"},{"issue":"2","key":"16360_CR20","doi-asserted-by":"publisher","first-page":"536","DOI":"10.7150\/ijbs.64537","volume":"18","author":"X Hu","year":"2022","unstructured":"Hu X, Chen R, Wei Q, Xu X. The Landscape Of Alpha Fetoprotein In Hepatocellular Carcinoma: Where Are We? Int J Biol Sci. 2022;18(2):536\u201351.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"16360_CR21","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12957-025-03765-7","volume":"23","author":"X Lv","year":"2025","unstructured":"Lv X, Zhang P, Zhang E, Yang S. Predictive factors and prognostic models for Hepatic arterial infusion chemotherapy in Hepatocellular carcinoma: a comprehensive review. World J Surg Oncol. 2025;23(1):166.","journal-title":"World J Surg Oncol"},{"issue":"1","key":"16360_CR22","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1186\/s12885-025-14240-7","volume":"25","author":"H Yang","year":"2025","unstructured":"Yang H, Shen S, Yang Y, Zhou H, Xiang B. Platelet-albumin-bilirubin versus albumin-bilirubin as a predictor of long-term survival for hepatitis B-Induced hepatocellular carcinoma after hepatic resection. BMC Cancer. 2025;25(1):855.","journal-title":"BMC Cancer"},{"issue":"3","key":"16360_CR23","doi-asserted-by":"publisher","first-page":"93","DOI":"10.14701\/kjhbps.2012.16.3.93","volume":"16","author":"J Byeon","year":"2012","unstructured":"Byeon J, Cho E, Kim SB, Choi DW. Extrahepatic recurrence of hepatocellular carcinoma after curative hepatic resection. Korean J Hepatobiliary Pancreat Surg. 2012;16(3):93\u20137.","journal-title":"Korean J Hepatobiliary Pancreat Surg"},{"issue":"37","key":"16360_CR24","doi-asserted-by":"publisher","first-page":"61203","DOI":"10.18632\/oncotarget.18049","volume":"8","author":"H Zhao","year":"2017","unstructured":"Zhao H, Hua Y, Lu Z, Gu S, Zhu L, Ji Y, Qiu Y, Dai T, Jin H. Prognostic value and preoperative predictors of microvascular invasion in solitary hepatocellular carcinoma\u2009\u2264\u20095\u00a0cm without macrovascular invasion. Oncotarget. 2017;8(37):61203\u201314.","journal-title":"Oncotarget"},{"issue":"11","key":"16360_CR25","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1002\/bjs.5102","volume":"92","author":"M Lu","year":"2005","unstructured":"Lu M, Yin X, Xie X, Xu H, Xu Z, Liu G, Kuang M, Zheng Y. Percutaneous thermal ablation for recurrent hepatocellular carcinoma after hepatectomy. Brit J Surg. 2005;92(11):1393\u20138.","journal-title":"Brit J Surg"},{"issue":"6","key":"16360_CR26","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1097\/JS9.0000000000001467","volume":"110","author":"L Liu","year":"2024","unstructured":"Liu L, Qin S, Lin K, Xu Q, Yang Y, Cai J, Zeng Y, Yuan S, Xiang B, Lau WY, et al. Development and comprehensive validation of a predictive prognosis model for very early HCC recurrence within one year after curative resection: a multicenter cohort study. Int J Surg. 2024;110(6):3401\u201311.","journal-title":"Int J Surg"},{"issue":"3","key":"16360_CR27","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s005350300038","volume":"38","author":"M Kudo","year":"2003","unstructured":"Kudo M, Chung H, Osaki Y. Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score). J Gastroenterol. 2003;38(3):207\u201315.","journal-title":"J Gastroenterol"},{"key":"16360_CR28","doi-asserted-by":"crossref","unstructured":"Pi\u00f1ero F, Dirchwolf M, Pess\u00f4a MG. Biomarkers in hepatocellular carcinoma: diagnosis, prognosis and treatment response assessment. Cells-Basel. 2020;9(6):1370.","DOI":"10.3390\/cells9061370"},{"issue":"3","key":"16360_CR29","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","volume":"76","author":"M Reig","year":"2022","unstructured":"Reig M, Forner A, Rimola J, Ferrer-F\u00e0brega J, Burrel M, Garcia-Criado \u00c1, Kelley RK, Galle PR, Mazzaferro V, Salem R, et al. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update. J Hepatol. 2022;76(3):681\u201393.","journal-title":"J Hepatol"},{"issue":"2","key":"16360_CR30","doi-asserted-by":"publisher","first-page":"109461","DOI":"10.1016\/j.ejso.2024.109461","volume":"51","author":"T Takamoto","year":"2025","unstructured":"Takamoto T, Nara S, Ban D, Mizui T, Mukai M, Esaki M, Shimada K. Chronological evolution in liver resection for hepatocellular carcinoma: Prognostic trends across three decades in early to advanced stages. EJSO-Eur J Surg Onc. 2025;51(2):109461.","journal-title":"EJSO-Eur J Surg Onc"},{"issue":"3","key":"16360_CR31","doi-asserted-by":"publisher","first-page":"e249194","DOI":"10.1371\/journal.pone.0249194","volume":"16","author":"Y Yen","year":"2021","unstructured":"Yen Y, Cheng Y, Wang J, Lin C, Chen C, Wang C. Adherence to the modified Barcelona Clinic Liver Cancer guidelines: Results from a high-volume liver surgery center in East Asias. PLoS ONE. 2021;16(3):e249194.","journal-title":"PLoS ONE"},{"key":"16360_CR32","doi-asserted-by":"publisher","first-page":"8945798","DOI":"10.1155\/2019\/8945798","volume":"2019","author":"M Tsai","year":"2019","unstructured":"Tsai M, Yen Y, Huang P, Sou F, Lin C, Cho W, Wang H, Chen D, Chang K, Wu C, et al. The Pre- and Postoperative FIB-4 Indexes Are Good Predictors to the Outcomes of HBV-Related HCC Patients after Resection. Gastroent Res Pract. 2019;2019:8945798.","journal-title":"Gastroent Res Pract"},{"issue":"4","key":"16360_CR33","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4174\/astr.2023.104.4.195","volume":"104","author":"SO Yun","year":"2023","unstructured":"Yun SO, Kim JM, Rhu J, Choi G, Joh J. Fibrosis-4 index, a predictor for prognosis of hepatocellular carcinoma patients after curative hepatectomy even in hepatitis B virus dominant populations. Ann Surg Treat Res. 2023;104(4):195\u2013204.","journal-title":"Ann Surg Treat Res"},{"key":"16360_CR34","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.3389\/fonc.2020.01316","volume":"10","author":"T Wang","year":"2020","unstructured":"Wang T, Zhang K. New Blood Biomarkers for the Diagnosis of AFP-Negative Hepatocellular Carcinoma. Front Oncol. 2020;10:1316.","journal-title":"Front Oncol"},{"issue":"1","key":"16360_CR35","doi-asserted-by":"publisher","first-page":"20827","DOI":"10.1038\/s41598-023-47580-0","volume":"13","author":"L Kocheise","year":"2023","unstructured":"Kocheise L, Schoenlein M, Behrends B, Joerg V, Casar C, Fruendt TW, Renn\u00e9 T, Heumann A, Li J, Huber S, et al. EpCAM-positive circulating tumor cells and serum AFP levels predict outcome after curative resection of hepatocellular carcinoma. Sci Rep-UK. 2023;13(1):20827.","journal-title":"Sci Rep-UK"},{"issue":"6","key":"16360_CR36","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1002\/hep.31207","volume":"72","author":"C Saillard","year":"2020","unstructured":"Saillard C, Schmauch B, Laifa O, Moarii M, Toldo S, Zaslavskiy M, Pronier E, Laurent A, Amaddeo G, Regnault H, et al. Predicting Survival After Hepatocellular Carcinoma Resection Using Deep Learning on Histological Slides. Hepatology. 2020;72(6):2000\u201313.","journal-title":"Hepatology"},{"key":"16360_CR37","doi-asserted-by":"publisher","first-page":"821","DOI":"10.2147\/JHC.S411521","volume":"10","author":"J Zhou","year":"2023","unstructured":"Zhou J, Yang D. Prognostic Significance of Hemoglobin, Albumin, Lymphocyte and Platelet (HALP) Score in Hepatocellular Carcinoma. J Hepatocell Carcino. 2023;10:821\u201331.","journal-title":"J Hepatocell Carcino"},{"issue":"3","key":"16360_CR38","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3350\/cmh.2024.0103","volume":"30","author":"C Ho","year":"2024","unstructured":"Ho C, Tan EC, Lee P, Chu C, Huang Y, Huo T, Su Y, Hou M, Wu J, Su C. Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma. Clin Mol Hepatol. 2024;30(3):406\u201320.","journal-title":"Clin Mol Hepatol"},{"issue":"1","key":"16360_CR39","doi-asserted-by":"publisher","first-page":"8034","DOI":"10.1038\/s41598-024-58205-5","volume":"14","author":"Y Tian","year":"2024","unstructured":"Tian Y, Niu H, Xu F, Shang-Guan P, Song W. ALBI score combined with FIB-4 index to predict post-hepatectomy liver failure in patients with hepatocellular carcinoma. Sci Rep-UK. 2024;14(1):8034.","journal-title":"Sci Rep-UK"},{"issue":"4","key":"16360_CR40","doi-asserted-by":"publisher","first-page":"516","DOI":"10.3350\/cmh.2020.0016","volume":"26","author":"J Kim","year":"2020","unstructured":"Kim J, Kang W, Sinn DH, Gwak G, Paik Y, Choi MS, Lee JH, Koh KC, Paik SW. Substantial risk of recurrence even after 5 recurrence-free years in early-stage hepatocellular carcinoma patients. Clin Mol Hepatol. 2020;26(4):516\u201328.","journal-title":"Clin Mol Hepatol"},{"issue":"19","key":"16360_CR41","doi-asserted-by":"publisher","first-page":"e38444","DOI":"10.1016\/j.heliyon.2024.e38444","volume":"10","author":"M Liu","year":"2024","unstructured":"Liu M, Wen Y. Point-of-care testing for early-stage liver cancer diagnosis and personalized medicine: Biomarkers, current technologies and perspectives. Heliyon. 2024;10(19):e38444.","journal-title":"Heliyon"},{"issue":"1","key":"16360_CR42","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12916-021-02201-3","volume":"20","author":"B Luo","year":"2022","unstructured":"Luo B, Ma F, Liu H, Hu J, Rao L, Liu C, Jiang Y, Kuangzeng S, Lin X, Wang C, et al. Cell-free DNA methylation markers for differential diagnosis of hepatocellular carcinoma. BMC Med. 2022;20(1):8.","journal-title":"BMC Med"},{"issue":"2","key":"16360_CR43","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3748\/wjg.v28.i2.216","volume":"28","author":"H Hanif","year":"2022","unstructured":"Hanif H, Ali MJ, Susheela AT, Khan IW, Luna-Cuadros MA, Khan MM, Lau DT. Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma. World J Gastroentero. 2022;28(2):216\u201329.","journal-title":"World J Gastroentero"},{"issue":"8","key":"16360_CR44","doi-asserted-by":"publisher","first-page":"6014","DOI":"10.18632\/oncotarget.3338","volume":"6","author":"R Gao","year":"2015","unstructured":"Gao R, Cai C, Gan J, Yang X, Shuang Z, Liu M, Li S, Tang H. miR-1236 down-regulates alpha-fetoprotein, thus causing PTEN accumulation, which inhibits the PI3K\/Akt pathway and malignant phenotype in hepatoma cells. Oncotarget. 2015;6(8):6014\u201328.","journal-title":"Oncotarget"},{"issue":"1","key":"16360_CR45","doi-asserted-by":"publisher","first-page":"115","DOI":"10.18632\/aging.101363","volume":"10","author":"P Li","year":"2018","unstructured":"Li P, Chen P, Peng X, Ma C, Zhang W, Dai X. HOXC6 predicts invasion and poor survival in hepatocellular carcinoma by driving epithelial-mesenchymal transition. Aging. 2018;10(1):115\u201330.","journal-title":"Aging"},{"key":"16360_CR46","doi-asserted-by":"publisher","first-page":"107593","DOI":"10.1016\/j.compbiomed.2023.107593","volume":"167","author":"R Wu","year":"2023","unstructured":"Wu R, Gao Y, Zhao X, Guo S, Zhou H, Zhang Y, Hou Y, Mei L, Zhi H, Wang P, et al. Tumor biology, immune infiltration and liver function define seven hepatocellular carcinoma subtypes linked to distinct drivers, survival and drug response. Comput Biol Med. 2023;167:107593.","journal-title":"Comput Biol Med"},{"issue":"6","key":"16360_CR47","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","volume":"33","author":"PJ Johnson","year":"2015","unstructured":"Johnson PJ, Berhane S, Kagebayashi C, Satomura S, Teng M, Reeves HL, O\u2019Beirne J, Fox R, Skowronska A, Palmer D, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol. 2015;33(6):550\u20138.","journal-title":"J Clin Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16360-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16360-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16360-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T02:03:11Z","timestamp":1788228191000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16360-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,20]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16360"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16360-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,20]]},"assertion":[{"value":"19 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was reviewed and approved by the ethics committees of Guangxi Medical University Cancer Hospital (approval number: KY2026390) and The First People\u2019s Hospital of Changde City(approval number: 2025-260-01).Due to the retrospective nature of this study, the requirement for individual informed consent was waived by the ethics committee. All data analyses were performed in strict accordance with the principles of the Declaration of Helsinki, as well as the ethical guidelines established by Guangxi Medical University Cancer Hospital and The First People\u2019s Hospital of Changde City.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1037"}}